Cellromax Science Co., Ltd. (KOSDAQ:471820)
3,970.00
+60.00 (1.53%)
At close: Nov 3, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 44.32 billion as of November 3, 2026. It is the 33,152nd most valuable company in the world and the 1,877th biggest in South Korea. Its market cap has decreased by 22.15% in one year.
Market Cap
44.32B
Enterprise Value
35.21B
Revenue
19.60B
Global Rank
Country Rank
#1,877 South Korea
PE Ratio
14.55
ChartMarket Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 44.32B, a decrease of -52.18%. That is a compound annual growth rate of -32.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 44.32B | -39.76% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Black Yak I&C Co.,Ltd | 82.79B |
| C-SITE | 58.88B |
| ERCOHS Agricultural Corporation Co.,Ltd | 51.14B |
| NBR Motion | 47.45B |
| Laseroptek | 41.56B |
| GITSN | 36.46B |
| ALT Co., Ltd. | 34.99B |
| Korea No.14 Special Purpose Acquisition | 31.69B |